ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Androgen Receptor (AR) Antagonist Market Research Report 2026
Published Date: 2026-03-30
|
Report Code: QYRE-Auto-29W17150
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Androgen Receptor AR Antagonist Market Research Report 2024
BUY CHAPTERS

Global Androgen Receptor (AR) Antagonist Market Research Report 2026

Code: QYRE-Auto-29W17150
Report
2026-03-30
Pages:116
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
R&D Systems
Bayer
Janssen Pharmaceuticals
Pfizer Inc
Astellas Pharma
Hengrui Medicine
Kaituo Pharmaceutical
R&D Systems

Androgen Receptor (AR) Antagonist Market

The global Androgen Receptor (AR) Antagonist market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Androgen Receptor (AR) Antagonist competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Androgen receptor (AR) antagonists are a class of drugs that bind to androgen receptors, thereby preventing or reducing the biological effects of androgens.
The North American market for Androgen Receptor (AR) Antagonist is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Androgen Receptor (AR) Antagonist is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of Androgen Receptor (AR) Antagonist include R&D Systems, Bayer, Janssen Pharmaceuticals, Pfizer, Astellas Pharma, Kaituo Pharmaceutical, Hengrui Medicine, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Androgen Receptor (AR) Antagonist market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Androgen Receptor (AR) Antagonist. The Androgen Receptor (AR) Antagonist market size, estimates, and forecasts are provided in terms of sales volume (Kilotons) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Androgen Receptor (AR) Antagonist market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Androgen Receptor (AR) Antagonist manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Androgen Receptor (AR) Antagonist Market Report

Report Metric Details
Report Name Androgen Receptor (AR) Antagonist Market
Segment by Type
  • Steroidal AR Antagonists
  • Nonsteroidal AR Antagonists
by Application
  • Prostate Cancer
  • Breast Cancer
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company R&D Systems, Bayer, Janssen Pharmaceuticals, Pfizer, Astellas Pharma, Kaituo Pharmaceutical, Hengrui Medicine
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Androgen Receptor (AR) Antagonist manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Androgen Receptor (AR) Antagonist sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

Who are the main players in the Androgen Receptor (AR) Antagonist Market report?

Ans: The main players in the Androgen Receptor (AR) Antagonist Market are R&D Systems, Bayer, Janssen Pharmaceuticals, Pfizer, Astellas Pharma, Kaituo Pharmaceutical, Hengrui Medicine

What are the Application segmentation covered in the Androgen Receptor (AR) Antagonist Market report?

Ans: The Applications covered in the Androgen Receptor (AR) Antagonist Market report are Prostate Cancer, Breast Cancer, Others

What are the Type segmentation covered in the Androgen Receptor (AR) Antagonist Market report?

Ans: The Types covered in the Androgen Receptor (AR) Antagonist Market report are Steroidal AR Antagonists, Nonsteroidal AR Antagonists

1 Androgen Receptor (AR) Antagonist Market Overview
1.1 Product Definition
1.2 Androgen Receptor (AR) Antagonist by Type
1.2.1 Global Androgen Receptor (AR) Antagonist Market Value by Type: 2025 vs 2032
1.2.2 Steroidal AR Antagonists
1.2.3 Nonsteroidal AR Antagonists
1.3 Androgen Receptor (AR) Antagonist by Application
1.3.1 Global Androgen Receptor (AR) Antagonist Market Value by Application: 2025 vs 2032
1.3.2 Prostate Cancer
1.3.3 Breast Cancer
1.3.4 Others
1.4 Global Androgen Receptor (AR) Antagonist Market Size Estimates and Forecasts
1.4.1 Global Androgen Receptor (AR) Antagonist Revenue 2021–2032
1.4.2 Global Androgen Receptor (AR) Antagonist Sales 2021–2032
1.4.3 Global Androgen Receptor (AR) Antagonist Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Androgen Receptor (AR) Antagonist Market Competition by Manufacturers
2.1 Global Androgen Receptor (AR) Antagonist Sales Market Share by Manufacturers (2021–2026)
2.2 Global Androgen Receptor (AR) Antagonist Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Androgen Receptor (AR) Antagonist Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Androgen Receptor (AR) Antagonist, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Androgen Receptor (AR) Antagonist, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Androgen Receptor (AR) Antagonist, Product Types and Applications
2.7 Global Key Manufacturers of Androgen Receptor (AR) Antagonist, Date of Entry into the Industry
2.8 Global Androgen Receptor (AR) Antagonist Market Competitive Situation and Trends
2.8.1 Global Androgen Receptor (AR) Antagonist Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Androgen Receptor (AR) Antagonist Players Market Share by Revenue
2.8.3 Global Androgen Receptor (AR) Antagonist Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Androgen Receptor (AR) Antagonist Market Scenario by Region
3.1 Global Androgen Receptor (AR) Antagonist Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Androgen Receptor (AR) Antagonist Sales by Region: 2021–2032
3.2.1 Global Androgen Receptor (AR) Antagonist Sales by Region: 2021–2026
3.2.2 Global Androgen Receptor (AR) Antagonist Sales by Region: 2027–2032
3.3 Global Androgen Receptor (AR) Antagonist Revenue by Region: 2021–2032
3.3.1 Global Androgen Receptor (AR) Antagonist Revenue by Region: 2021–2026
3.3.2 Global Androgen Receptor (AR) Antagonist Revenue by Region: 2027–2032
3.4 North America Androgen Receptor (AR) Antagonist Market Facts & Figures by Country
3.4.1 North America Androgen Receptor (AR) Antagonist Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Androgen Receptor (AR) Antagonist Sales by Country (2021–2032)
3.4.3 North America Androgen Receptor (AR) Antagonist Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Androgen Receptor (AR) Antagonist Market Facts & Figures by Country
3.5.1 Europe Androgen Receptor (AR) Antagonist Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Androgen Receptor (AR) Antagonist Sales by Country (2021–2032)
3.5.3 Europe Androgen Receptor (AR) Antagonist Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Androgen Receptor (AR) Antagonist Market Facts & Figures by Region
3.6.1 Asia Pacific Androgen Receptor (AR) Antagonist Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Androgen Receptor (AR) Antagonist Sales by Region (2021–2032)
3.6.3 Asia Pacific Androgen Receptor (AR) Antagonist Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Androgen Receptor (AR) Antagonist Market Facts & Figures by Country
3.7.1 Latin America Androgen Receptor (AR) Antagonist Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Androgen Receptor (AR) Antagonist Sales by Country (2021–2032)
3.7.3 Latin America Androgen Receptor (AR) Antagonist Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Androgen Receptor (AR) Antagonist Market Facts & Figures by Country
3.8.1 Middle East and Africa Androgen Receptor (AR) Antagonist Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Androgen Receptor (AR) Antagonist Sales by Country (2021–2032)
3.8.3 Middle East and Africa Androgen Receptor (AR) Antagonist Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Androgen Receptor (AR) Antagonist Sales by Type (2021–2032)
4.1.1 Global Androgen Receptor (AR) Antagonist Sales by Type (2021–2026)
4.1.2 Global Androgen Receptor (AR) Antagonist Sales by Type (2027–2032)
4.1.3 Global Androgen Receptor (AR) Antagonist Sales Market Share by Type (2021–2032)
4.2 Global Androgen Receptor (AR) Antagonist Revenue by Type (2021–2032)
4.2.1 Global Androgen Receptor (AR) Antagonist Revenue by Type (2021–2026)
4.2.2 Global Androgen Receptor (AR) Antagonist Revenue by Type (2027–2032)
4.2.3 Global Androgen Receptor (AR) Antagonist Revenue Market Share by Type (2021–2032)
4.3 Global Androgen Receptor (AR) Antagonist Price by Type (2021–2032)
5 Segment by Application
5.1 Global Androgen Receptor (AR) Antagonist Sales by Application (2021–2032)
5.1.1 Global Androgen Receptor (AR) Antagonist Sales by Application (2021–2026)
5.1.2 Global Androgen Receptor (AR) Antagonist Sales by Application (2027–2032)
5.1.3 Global Androgen Receptor (AR) Antagonist Sales Market Share by Application (2021–2032)
5.2 Global Androgen Receptor (AR) Antagonist Revenue by Application (2021–2032)
5.2.1 Global Androgen Receptor (AR) Antagonist Revenue by Application (2021–2026)
5.2.2 Global Androgen Receptor (AR) Antagonist Revenue by Application (2027–2032)
5.2.3 Global Androgen Receptor (AR) Antagonist Revenue Market Share by Application (2021–2032)
5.3 Global Androgen Receptor (AR) Antagonist Price by Application (2021–2032)
6 Key Companies Profiled
6.1 R&D Systems
6.1.1 R&D Systems Company Information
6.1.2 R&D Systems Description and Business Overview
6.1.3 R&D Systems Androgen Receptor (AR) Antagonist Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 R&D Systems Androgen Receptor (AR) Antagonist Product Portfolio
6.1.5 R&D Systems Recent Developments/Updates
6.2 Bayer
6.2.1 Bayer Company Information
6.2.2 Bayer Description and Business Overview
6.2.3 Bayer Androgen Receptor (AR) Antagonist Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Bayer Androgen Receptor (AR) Antagonist Product Portfolio
6.2.5 Bayer Recent Developments/Updates
6.3 Janssen Pharmaceuticals
6.3.1 Janssen Pharmaceuticals Company Information
6.3.2 Janssen Pharmaceuticals Description and Business Overview
6.3.3 Janssen Pharmaceuticals Androgen Receptor (AR) Antagonist Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Janssen Pharmaceuticals Androgen Receptor (AR) Antagonist Product Portfolio
6.3.5 Janssen Pharmaceuticals Recent Developments/Updates
6.4 Pfizer
6.4.1 Pfizer Company Information
6.4.2 Pfizer Description and Business Overview
6.4.3 Pfizer Androgen Receptor (AR) Antagonist Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Pfizer Androgen Receptor (AR) Antagonist Product Portfolio
6.4.5 Pfizer Recent Developments/Updates
6.5 Astellas Pharma
6.5.1 Astellas Pharma Company Information
6.5.2 Astellas Pharma Description and Business Overview
6.5.3 Astellas Pharma Androgen Receptor (AR) Antagonist Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Astellas Pharma Androgen Receptor (AR) Antagonist Product Portfolio
6.5.5 Astellas Pharma Recent Developments/Updates
6.6 Kaituo Pharmaceutical
6.6.1 Kaituo Pharmaceutical Company Information
6.6.2 Kaituo Pharmaceutical Description and Business Overview
6.6.3 Kaituo Pharmaceutical Androgen Receptor (AR) Antagonist Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Kaituo Pharmaceutical Androgen Receptor (AR) Antagonist Product Portfolio
6.6.5 Kaituo Pharmaceutical Recent Developments/Updates
6.7 Hengrui Medicine
6.7.1 Hengrui Medicine Company Information
6.7.2 Hengrui Medicine Description and Business Overview
6.7.3 Hengrui Medicine Androgen Receptor (AR) Antagonist Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Hengrui Medicine Androgen Receptor (AR) Antagonist Product Portfolio
6.7.5 Hengrui Medicine Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Androgen Receptor (AR) Antagonist Industry Chain Analysis
7.2 Androgen Receptor (AR) Antagonist Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Androgen Receptor (AR) Antagonist Production Mode & Process Analysis
7.4 Androgen Receptor (AR) Antagonist Sales and Marketing
7.4.1 Androgen Receptor (AR) Antagonist Sales Channels
7.4.2 Androgen Receptor (AR) Antagonist Distributors
7.5 Androgen Receptor (AR) Antagonist Customer Analysis
8 Androgen Receptor (AR) Antagonist Market Dynamics
8.1 Androgen Receptor (AR) Antagonist Industry Trends
8.2 Androgen Receptor (AR) Antagonist Market Drivers
8.3 Androgen Receptor (AR) Antagonist Market Challenges
8.4 Androgen Receptor (AR) Antagonist Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
R&D Systems
Bayer
Janssen Pharmaceuticals
Pfizer Inc
Astellas Pharma
Hengrui Medicine
Kaituo Pharmaceutical
R&D Systems
List of Tables
 Table 1. Global Androgen Receptor (AR) Antagonist Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Androgen Receptor (AR) Antagonist Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Androgen Receptor (AR) Antagonist Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Androgen Receptor (AR) Antagonist Sales (Kilotons) of Key Manufacturers (2021–2026)
 Table 5. Global Androgen Receptor (AR) Antagonist Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Androgen Receptor (AR) Antagonist Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Androgen Receptor (AR) Antagonist Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Androgen Receptor (AR) Antagonist Average Price (US$/Ton) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Androgen Receptor (AR) Antagonist, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Androgen Receptor (AR) Antagonist, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Androgen Receptor (AR) Antagonist, Product Types and Applications
 Table 12. Global Key Manufacturers of Androgen Receptor (AR) Antagonist, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Androgen Receptor (AR) Antagonist Companies by Tier (Tier 1, Tier 2, Tier 3), based on Androgen Receptor (AR) Antagonist Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Androgen Receptor (AR) Antagonist Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Androgen Receptor (AR) Antagonist Sales by Region (Kilotons), 2021–2026
 Table 18. Global Androgen Receptor (AR) Antagonist Sales Market Share by Region (2021–2026)
 Table 19. Global Androgen Receptor (AR) Antagonist Sales by Region (Kilotons), 2027–2032
 Table 20. Global Androgen Receptor (AR) Antagonist Sales Market Share by Region (2027–2032)
 Table 21. Global Androgen Receptor (AR) Antagonist Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Androgen Receptor (AR) Antagonist Revenue Market Share by Region (2021–2026)
 Table 23. Global Androgen Receptor (AR) Antagonist Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Androgen Receptor (AR) Antagonist Revenue Market Share by Region (2027–2032)
 Table 25. North America Androgen Receptor (AR) Antagonist Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Androgen Receptor (AR) Antagonist Sales by Country (Kilotons), 2021–2026
 Table 27. North America Androgen Receptor (AR) Antagonist Sales by Country (Kilotons), 2027–2032
 Table 28. North America Androgen Receptor (AR) Antagonist Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Androgen Receptor (AR) Antagonist Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Androgen Receptor (AR) Antagonist Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Androgen Receptor (AR) Antagonist Sales by Country (Kilotons), 2021–2026
 Table 32. Europe Androgen Receptor (AR) Antagonist Sales by Country (Kilotons), 2027–2032
 Table 33. Europe Androgen Receptor (AR) Antagonist Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Androgen Receptor (AR) Antagonist Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Androgen Receptor (AR) Antagonist Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Androgen Receptor (AR) Antagonist Sales by Region (Kilotons), 2021–2026
 Table 37. Asia Pacific Androgen Receptor (AR) Antagonist Sales by Region (Kilotons), 2027–2032
 Table 38. Asia Pacific Androgen Receptor (AR) Antagonist Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Androgen Receptor (AR) Antagonist Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Androgen Receptor (AR) Antagonist Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Androgen Receptor (AR) Antagonist Sales by Country (Kilotons), 2021–2026
 Table 42. Latin America Androgen Receptor (AR) Antagonist Sales by Country (Kilotons), 2027–2032
 Table 43. Latin America Androgen Receptor (AR) Antagonist Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Androgen Receptor (AR) Antagonist Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Androgen Receptor (AR) Antagonist Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Androgen Receptor (AR) Antagonist Sales by Country (Kilotons), 2021–2026
 Table 47. Middle East and Africa Androgen Receptor (AR) Antagonist Sales by Country (Kilotons), 2027–2032
 Table 48. Middle East and Africa Androgen Receptor (AR) Antagonist Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Androgen Receptor (AR) Antagonist Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Androgen Receptor (AR) Antagonist Sales (Kilotons) by Type (2021–2026)
 Table 51. Global Androgen Receptor (AR) Antagonist Sales (Kilotons) by Type (2027–2032)
 Table 52. Global Androgen Receptor (AR) Antagonist Sales Market Share by Type (2021–2026)
 Table 53. Global Androgen Receptor (AR) Antagonist Sales Market Share by Type (2027–2032)
 Table 54. Global Androgen Receptor (AR) Antagonist Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Androgen Receptor (AR) Antagonist Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Androgen Receptor (AR) Antagonist Revenue Market Share by Type (2021–2026)
 Table 57. Global Androgen Receptor (AR) Antagonist Revenue Market Share by Type (2027–2032)
 Table 58. Global Androgen Receptor (AR) Antagonist Price (US$/Ton) by Type (2021–2026)
 Table 59. Global Androgen Receptor (AR) Antagonist Price (US$/Ton) by Type (2027–2032)
 Table 60. Global Androgen Receptor (AR) Antagonist Sales (Kilotons) by Application (2021–2026)
 Table 61. Global Androgen Receptor (AR) Antagonist Sales (Kilotons) by Application (2027–2032)
 Table 62. Global Androgen Receptor (AR) Antagonist Sales Market Share by Application (2021–2026)
 Table 63. Global Androgen Receptor (AR) Antagonist Sales Market Share by Application (2027–2032)
 Table 64. Global Androgen Receptor (AR) Antagonist Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Androgen Receptor (AR) Antagonist Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Androgen Receptor (AR) Antagonist Revenue Market Share by Application (2021–2026)
 Table 67. Global Androgen Receptor (AR) Antagonist Revenue Market Share by Application (2027–2032)
 Table 68. Global Androgen Receptor (AR) Antagonist Price (US$/Ton) by Application (2021–2026)
 Table 69. Global Androgen Receptor (AR) Antagonist Price (US$/Ton) by Application (2027–2032)
 Table 70. R&D Systems Company Information
 Table 71. R&D Systems Description and Business Overview
 Table 72. R&D Systems Androgen Receptor (AR) Antagonist Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton), and Gross Margin (2021–2026)
 Table 73. R&D Systems Androgen Receptor (AR) Antagonist Product
 Table 74. R&D Systems Recent Developments/Updates
 Table 75. Bayer Company Information
 Table 76. Bayer Description and Business Overview
 Table 77. Bayer Androgen Receptor (AR) Antagonist Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton), and Gross Margin (2021–2026)
 Table 78. Bayer Androgen Receptor (AR) Antagonist Product
 Table 79. Bayer Recent Developments/Updates
 Table 80. Janssen Pharmaceuticals Company Information
 Table 81. Janssen Pharmaceuticals Description and Business Overview
 Table 82. Janssen Pharmaceuticals Androgen Receptor (AR) Antagonist Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton), and Gross Margin (2021–2026)
 Table 83. Janssen Pharmaceuticals Androgen Receptor (AR) Antagonist Product
 Table 84. Janssen Pharmaceuticals Recent Developments/Updates
 Table 85. Pfizer Company Information
 Table 86. Pfizer Description and Business Overview
 Table 87. Pfizer Androgen Receptor (AR) Antagonist Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton), and Gross Margin (2021–2026)
 Table 88. Pfizer Androgen Receptor (AR) Antagonist Product
 Table 89. Pfizer Recent Developments/Updates
 Table 90. Astellas Pharma Company Information
 Table 91. Astellas Pharma Description and Business Overview
 Table 92. Astellas Pharma Androgen Receptor (AR) Antagonist Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton), and Gross Margin (2021–2026)
 Table 93. Astellas Pharma Androgen Receptor (AR) Antagonist Product
 Table 94. Astellas Pharma Recent Developments/Updates
 Table 95. Kaituo Pharmaceutical Company Information
 Table 96. Kaituo Pharmaceutical Description and Business Overview
 Table 97. Kaituo Pharmaceutical Androgen Receptor (AR) Antagonist Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton), and Gross Margin (2021–2026)
 Table 98. Kaituo Pharmaceutical Androgen Receptor (AR) Antagonist Product
 Table 99. Kaituo Pharmaceutical Recent Developments/Updates
 Table 100. Hengrui Medicine Company Information
 Table 101. Hengrui Medicine Description and Business Overview
 Table 102. Hengrui Medicine Androgen Receptor (AR) Antagonist Sales (Kilotons), Revenue (US$ Million), Price (US$/Ton), and Gross Margin (2021–2026)
 Table 103. Hengrui Medicine Androgen Receptor (AR) Antagonist Product
 Table 104. Hengrui Medicine Recent Developments/Updates
 Table 105. Key Raw Materials Lists
 Table 106. Raw Materials Key Suppliers Lists
 Table 107. Androgen Receptor (AR) Antagonist Distributors List
 Table 108. Androgen Receptor (AR) Antagonist Customers List
 Table 109. Androgen Receptor (AR) Antagonist Market Trends
 Table 110. Androgen Receptor (AR) Antagonist Market Drivers
 Table 111. Androgen Receptor (AR) Antagonist Market Challenges
 Table 112. Androgen Receptor (AR) Antagonist Market Restraints
 Table 113. Research Programs/Design for This Report
 Table 114. Key Data Information from Secondary Sources
 Table 115. Key Data Information from Primary Sources
 Table 116. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Androgen Receptor (AR) Antagonist
 Figure 2. Global Androgen Receptor (AR) Antagonist Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Androgen Receptor (AR) Antagonist Market Share by Type: 2025 & 2032
 Figure 4. Steroidal AR Antagonists Product Picture
 Figure 5. Nonsteroidal AR Antagonists Product Picture
 Figure 6. Global Androgen Receptor (AR) Antagonist Market Value by Application (US$ Million), 2021–2032
 Figure 7. Global Androgen Receptor (AR) Antagonist Market Share by Application: 2025 & 2032
 Figure 8. Prostate Cancer
 Figure 9. Breast Cancer
 Figure 10. Others
 Figure 11. Global Androgen Receptor (AR) Antagonist Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 12. Global Androgen Receptor (AR) Antagonist Market Size (US$ Million), 2021–2032
 Figure 13. Global Androgen Receptor (AR) Antagonist Sales (Kilotons), 2021–2032
 Figure 14. Global Androgen Receptor (AR) Antagonist Average Price (US$/Ton), 2021–2032
 Figure 15. Androgen Receptor (AR) Antagonist Report Years Considered
 Figure 16. Androgen Receptor (AR) Antagonist Sales Share by Manufacturers in 2025
 Figure 17. Global Androgen Receptor (AR) Antagonist Revenue Share by Manufacturers in 2025
 Figure 18. Top 5 and Top 10 Global Androgen Receptor (AR) Antagonist Players: Market Share by Revenue in Androgen Receptor (AR) Antagonist in 2025
 Figure 19. Androgen Receptor (AR) Antagonist Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 20. Global Androgen Receptor (AR) Antagonist Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 21. North America Androgen Receptor (AR) Antagonist Sales Market Share by Country (2021–2032)
 Figure 22. North America Androgen Receptor (AR) Antagonist Revenue Market Share by Country (2021–2032)
 Figure 23. United States Androgen Receptor (AR) Antagonist Revenue Growth Rate (US$ Million), 2021–2032
 Figure 24. Canada Androgen Receptor (AR) Antagonist Revenue Growth Rate (US$ Million), 2021–2032
 Figure 25. Europe Androgen Receptor (AR) Antagonist Sales Market Share by Country (2021–2032)
 Figure 26. Europe Androgen Receptor (AR) Antagonist Revenue Market Share by Country (2021–2032)
 Figure 27. Germany Androgen Receptor (AR) Antagonist Revenue Growth Rate (US$ Million), 2021–2032
 Figure 28. France Androgen Receptor (AR) Antagonist Revenue Growth Rate (US$ Million), 2021–2032
 Figure 29. U.K. Androgen Receptor (AR) Antagonist Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. Italy Androgen Receptor (AR) Antagonist Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. Russia Androgen Receptor (AR) Antagonist Revenue Growth Rate (US$ Million), 2021–2032
 Figure 32. Asia Pacific Androgen Receptor (AR) Antagonist Sales Market Share by Region (2021–2032)
 Figure 33. Asia Pacific Androgen Receptor (AR) Antagonist Revenue Market Share by Region (2021–2032)
 Figure 34. China Androgen Receptor (AR) Antagonist Revenue Growth Rate (US$ Million), 2021–2032
 Figure 35. Japan Androgen Receptor (AR) Antagonist Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. South Korea Androgen Receptor (AR) Antagonist Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. India Androgen Receptor (AR) Antagonist Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. Australia Androgen Receptor (AR) Antagonist Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. China Taiwan Androgen Receptor (AR) Antagonist Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. Southeast Asia Androgen Receptor (AR) Antagonist Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. Latin America Androgen Receptor (AR) Antagonist Sales Market Share by Country (2021–2032)
 Figure 42. Latin America Androgen Receptor (AR) Antagonist Revenue Market Share by Country (2021–2032)
 Figure 43. Mexico Androgen Receptor (AR) Antagonist Revenue Growth Rate (US$ Million), 2021–2032
 Figure 44. Brazil Androgen Receptor (AR) Antagonist Revenue Growth Rate (US$ Million), 2021–2032
 Figure 45. Argentina Androgen Receptor (AR) Antagonist Revenue Growth Rate (US$ Million), 2021–2032
 Figure 46. Colombia Androgen Receptor (AR) Antagonist Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. Middle East and Africa Androgen Receptor (AR) Antagonist Sales Market Share by Country (2021–2032)
 Figure 48. Middle East and Africa Androgen Receptor (AR) Antagonist Revenue Market Share by Country (2021–2032)
 Figure 49. Turkey Androgen Receptor (AR) Antagonist Revenue Growth Rate (US$ Million), 2021–2032
 Figure 50. Saudi Arabia Androgen Receptor (AR) Antagonist Revenue Growth Rate (US$ Million), 2021–2032
 Figure 51. UAE Androgen Receptor (AR) Antagonist Revenue Growth Rate (US$ Million), 2021–2032
 Figure 52. Global Sales Market Share of Androgen Receptor (AR) Antagonist by Type (2021–2032)
 Figure 53. Global Revenue Market Share of Androgen Receptor (AR) Antagonist by Type (2021–2032)
 Figure 54. Global Androgen Receptor (AR) Antagonist Price (US$/Ton) by Type (2021–2032)
 Figure 55. Global Sales Market Share of Androgen Receptor (AR) Antagonist by Application (2021–2032)
 Figure 56. Global Revenue Market Share of Androgen Receptor (AR) Antagonist by Application (2021–2032)
 Figure 57. Global Androgen Receptor (AR) Antagonist Price (US$/Ton) by Application (2021–2032)
 Figure 58. Androgen Receptor (AR) Antagonist Value Chain
 Figure 59. Channels of Distribution (Direct Vs Distribution)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS

Global Androgen Receptor AR Inhibitor Market Research Report 2025
Global Angiotensin II Type 1 Receptor AT1R Antagonists Market Research Report 2024
Global α adrenoreceptor Antagonists Market Research Report 2024
Global α blocker Market Research Report 2024
Global GnRH Receptor Antagonists Market Research Report 2024
Angiotensin Receptor Antagonists Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Purinergic Receptor Antagonists Market Research Report 2024
Angiotensin Receptor Blockers ARBs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global AT1 Receptor Antagonists Market Research Report 2024
Global Androgen Antagonist Market Insights Forecast to 2030
Global Alpha Blockers Market Research Report 2024
Global IL 23 Receptor Antagonist Market Research Report 2024
Global 5 HT Receptor Antagonist Market Research Report 2025
Global Aldosterone Receptor Antagonists Market Research Report 2024
Global Androgen Antibody Market Research Report 2024
Global Androgen Receptor Antagonist Market Research Report 2024
Global Melanocortin Receptor Agonist Drugs Market Research Report 2024
Global Estrogen Receptor Modulators Market Research Report 2024
Global Selective Estrogen Receptor Modulators Market Research Report 2024
Global Enzalutamide API Market
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions